Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Baxter
UBS
McKinsey
Merck
Cantor Fitzgerald
Fuji
McKesson
Harvard Business School
Dow

Generated: February 19, 2018

DrugPatentWatch Database Preview

ETHYOL Drug Profile

« Back to Dashboard

Which patents cover Ethyol, and when can generic versions of Ethyol launch?

Ethyol is a drug marketed by Clinigen Hlthcare and is included in one NDA.

The generic ingredient in ETHYOL is amifostine. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amifostine profile page.
Drug patent expirations by year for ETHYOL
Pharmacology for ETHYOL
Medical Subject Heading (MeSH) Categories for ETHYOL

US Patents and Regulatory Information for ETHYOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ETHYOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ETHYOL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe For Injection 500 mg/vial ➤ Subscribe 4/16/2004

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Johnson and Johnson
US Department of Justice
Cipla
Chinese Patent Office
Farmers Insurance
McKesson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot